PTEN is a tumor suppressor that inactivates the P13K/AKT pathway whose signaling is important for propagation of the cell cycle [103]. PTEN deficiency is associated with many malignancies, including breast [104] and prostate cancers [105], and disrupts chromosomal integrity by causing centromere breakage and translocations [106]. This evidence concerns the gene PTEN and prostate carcinoma.